This document is an excerpt from the EUR-Lex website
Document 32019R1966R(01)
Corrigendum to Commission Regulation (EU) 2019/1966 of 27 November 2019 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Official Journal of the European Union L 307 of 28 November 2019)
Corrigendum to Commission Regulation (EU) 2019/1966 of 27 November 2019 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Official Journal of the European Union L 307 of 28 November 2019)
Corrigendum to Commission Regulation (EU) 2019/1966 of 27 November 2019 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Official Journal of the European Union L 307 of 28 November 2019)
IO L 324, 13.12.2019, p. 81–89
(ES, EL, HR, IT, HU, NL, PL, SK)
IO L 324, 13.12.2019, p. 80–88
(BG, CS, DA, DE, ET, EN, FR, LV, LT, MT, PT, RO, SL, FI, SV)
ELI: http://data.europa.eu/eli/reg/2019/1966/corrigendum/2019-12-13/oj
13.12.2019 |
EN |
Official Journal of the European Union |
L 324/80 |
Corrigendum to Commission Regulation (EU) 2019/1966 of 27 November 2019 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products
(Official Journal of the European Union L 307 of 28 November 2019)
On page 19, Annex I and Annex II are replaced as follows:
‘ANNEX I
(1)
Annex II to Regulation (EC) No 1223/2009 is amended as follows:The following entries are added:
Reference number |
Substance identification |
||
Chemical name/INN |
CAS number |
EC number |
|
a |
b |
c |
d |
“1612 |
Phosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)methyl]-O,O-dimethyl phosphorodithioate; O,O-dimethyl-S-phthalimidomethyl phosphorodithioate |
732-11-6 |
211-987-4 |
1613 |
Potassium permanganate |
7722-64-7 |
231-760-3 |
1614 |
2-Benzyl-2-dimethylamino-4′- morpholinobutyrophenone |
119313-12-1 |
404-360-3 |
1615 |
Quizalofop-p-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2- yloxy)phenyloxy]propionate |
200509-41-7 |
414-200-4 |
1616 |
Propiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazole |
60207-90-1 |
262-104-4 |
1617 |
Pinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate |
243973-20-8 |
635-361-9 |
1618 |
Tetramethrin (ISO); (1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate |
7696-12-0 |
231-711-6 |
1619 |
(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylate |
1166-46-7 |
214-619-0 |
1620 |
Spirodiclofen (ISO); 3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate |
148477-71-8 |
604-636-5 |
1621 |
Reaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamine |
897393-42-9 |
447-920-2 |
1622 |
1-Vinylimidazole |
1072-63-5 |
214-012-0 |
1623 |
Amisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide |
348635-87-0 |
672-776-4” |
(2)
Annex III to Regulation (EC) No 1223/2009 is amended as follows:Entry 98 is replaced by the following:
“98 |
Benzoic acid, 2-hydroxy- (*1) |
Salicylic acid |
69-72-7 |
200-712-3 |
|
|
Not to be used in preparations for children under 3 years of age. |
Not to be used for children under 3 years of age (*2) |
||||
|
|
Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. |
|
|||||||||
Not to be used in oral products. |
||||||||||||
For purposes other than inhibiting the development of micro-organisms in the product. This purpose has to be apparent from the presentation of the product. |
(3)
Annex V to Regulation (EC) No 1223/2009 is amended as follows:Entry 3 is replaced by the following:
Reference number |
Substance Identification |
Conditions |
Wording of conditions of use and warnings |
|||||
Chemical name/INN |
Name of Common Ingredients Glossary |
CAS number |
EC number |
Product type, Body parts |
Maximum concentration in ready for use preparation |
Other |
|
|
a |
b |
c |
d |
e |
f |
g |
h |
i |
“3 |
Salicylic acid (*3) and its salts |
Salicylic acid |
69-72-7 |
200-712-3 |
|
0,5 % (acid) |
Not to be used in products for children under 3 years of age. |
Not to be used for children under 3 years of age (*4) |
Not to be used in oral products. |
||||||||
Not to be used in applications that may lead to exposure of the end-user’s lungs by inhalation. |
||||||||
Calcium salicylate, magnesium salicylate, MEA- salicylate, sodium salicylate, potassium salicylate, TEA- salicylate |
824-35-1, 18917-89-0, 59866- 70-5, 54-21-7, 578-36-9, 2174-16-5 |
212-525-4, 242-669-3, 261-963-2, 200-198-0, 209-421-6, 218-531-3 |
|
0,5 % (acid) |
Not to be used in products for children under 3 years of age, except for shampoos. |
Not to be used for children under 3 years of age (*5) |
‘ANNEX II
(1)
Annex II to Regulation (EC) No 1223/2009 is corrected as follows:
(a) |
entry 395 is replaced by the following:
|
(b) |
entry 1396 is replaced by the following:
|
(c) |
entry 1507 is replaced by the following:
|
(d) |
the following entries are added:
|
(2)
Annex III to Regulation (EC) No 1223/2009 is corrected as follows:
(a) |
entry 9 is replaced by the following:
|
(b) |
the following entry is added:
|
(*1) For use as a preservative see Annex V, No 3.
(*2) Solely for products which might be used for children under 3 years of age.”
(*3) For uses other than preservative, see Annex III, No 98.
(*4) Solely for products which might be used for children under 3 years of age
(*5) Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.”